Skip to content

*The primary uncemented Delta III Reversed Shoulder Prosthesis * A longterm follow-up study*

*The primary uncemented Delta III Reversed Shoulder Prosthesis * A longterm follow-up study* - Delta Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41327
Enrollment
70
Registered
2012-06-04
Start date
2012-10-31
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis shoulderprosthesis

Interventions

None listed

Sponsors

Tergooiziekenhuizen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients treated with primairy uncemented reversed shoulder prosthesis in the period between January 2000 and December 2006 by drs. M. de Vos in the Maartenskliniek (SMK) Nijmegen because of rheumatoid arthritis, cuffartheopathy, shoulder osteoarthritis. Age older than 18 years and willing to participate in the study.

Exclusion criteria

Exclusion criteria: Not complying with inclusion criteria. Age

Design outcomes

Primary

MeasureTime frame
Primary study parameters/ outcome are: 1. Survivalanalysis of the Delta III prosthesis 2. X-rays of the shoulder (AP, Y and axial direction). These x-rays will be retrospectively collected from the medical archives and newly taken during the long-term follow-up controlvisit. 3. Clinical scores and questionnaires, retrospectively collected from the medical archives and newly taken during the long-term follow-up controlvisit. - Constant * Murley Shoulderscore - Simple Shoulder Test - DASH score - VAS score 4. Fysical examination in which ongoing functional complaints and the range of motion are evaluated.

Secondary

MeasureTime frame
None

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)